Trial intelligence / Profile preview

FUM: Vaginal Estrogen and the Urinary Microbiome in OAB

NCT02835846Phase 4Completed

Sponsor
Loyola University Chicago
Start
Sep 2016
Primary completion
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Estrogen vaginal cream in overactive bladder (OAB), atrophic vaginitis, sponsored by Loyola University Chicago. Started Sep 2016; status: completed.

02

Drugs

Estrogen vaginal cream
03

Conditions

overactive bladder (OAB)atrophic vaginitis

Beyond the preview

Go deeper on NCT02835846.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02835846.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call